annual CFO:
$123.42M+$212.22M(+238.98%)Summary
- As of today (August 15, 2025), KRYS annual cash flow from operations is $123.42 million, with the most recent change of +$212.22 million (+238.98%) on December 31, 2024.
- During the last 3 years, KRYS annual CFO has risen by +$171.36 million (+357.46%).
- KRYS annual CFO is now at all-time high.
Performance
KRYS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$52.73M+$21.76M(+70.26%)Summary
- As of today (August 15, 2025), KRYS quarterly cash flow from operations is $52.73 million, with the most recent change of +$21.76 million (+70.26%) on June 30, 2025.
- Over the past year, KRYS quarterly CFO has increased by +$56.90 million (+1365.09%).
- KRYS quarterly CFO is now -10.41% below its all-time high of $58.86 million, reached on September 30, 2024.
Performance
KRYS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$195.40M+$56.90M(+41.08%)Summary
- As of today (August 15, 2025), KRYS TTM cash flow from operations is $195.40 million, with the most recent change of +$56.90 million (+41.08%) on June 30, 2025.
- Over the past year, KRYS TTM CFO has increased by +$212.14 million (+1267.39%).
- KRYS TTM CFO is now at all-time high.
Performance
KRYS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KRYS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +239.0% | +1365.1% | +1267.4% |
| 3 y3 years | +357.5% | +222.5% | +325.4% |
| 5 y5 years | +760.4% | +1143.3% | +966.6% |
KRYS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +222.7% | -10.4% | +222.5% | at high | +275.7% |
| 5 y | 5-year | at high | +222.7% | -10.4% | +222.5% | at high | +275.7% |
| alltime | all time | at high | +222.7% | -10.4% | +222.5% | at high | +275.7% |
KRYS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $52.73M(+70.3%) | $195.40M(+41.1%) |
| Mar 2025 | - | $30.97M(-41.4%) | $138.50M(+12.2%) |
| Dec 2024 | $123.42M(-239.0%) | $52.84M(-10.2%) | $123.42M(+94.8%) |
| Sep 2024 | - | $58.86M(-1512.1%) | $63.34M(-478.5%) |
| Jun 2024 | - | -$4.17M(-126.2%) | -$16.74M(-64.2%) |
| Mar 2024 | - | $15.89M(-319.7%) | -$46.76M(-47.3%) |
| Dec 2023 | -$88.80M(-11.7%) | -$7.23M(-65.9%) | -$88.80M(-14.5%) |
| Sep 2023 | - | -$21.23M(-37.9%) | -$103.90M(+1.5%) |
| Jun 2023 | - | -$34.19M(+30.7%) | -$102.36M(-8.0%) |
| Mar 2023 | - | -$26.16M(+17.1%) | -$111.23M(+10.6%) |
| Dec 2022 | -$100.57M(+109.8%) | -$22.33M(+13.4%) | -$100.57M(+1.4%) |
| Sep 2022 | - | -$19.69M(-54.3%) | -$99.14M(+14.3%) |
| Jun 2022 | - | -$43.06M(+177.9%) | -$86.71M(+61.2%) |
| Mar 2022 | - | -$15.49M(-25.9%) | -$53.78M(+12.2%) |
| Dec 2021 | -$47.94M | -$20.90M(+188.1%) | -$47.94M(+36.7%) |
| Sep 2021 | - | -$7.25M(-28.4%) | -$35.06M(+1.4%) |
| Jun 2021 | - | -$10.13M(+4.9%) | -$34.59M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$9.65M(+20.3%) | -$29.51M(+13.1%) |
| Dec 2020 | -$26.08M(+39.6%) | -$8.02M(+18.4%) | -$26.08M(+4.1%) |
| Sep 2020 | - | -$6.78M(+34.1%) | -$25.06M(+11.1%) |
| Jun 2020 | - | -$5.05M(-18.8%) | -$22.55M(+3.9%) |
| Mar 2020 | - | -$6.23M(-11.0%) | -$21.70M(+16.1%) |
| Dec 2019 | -$18.69M(+97.9%) | -$7.00M(+64.1%) | -$18.69M(+22.9%) |
| Sep 2019 | - | -$4.27M(+1.4%) | -$15.21M(+18.1%) |
| Jun 2019 | - | -$4.21M(+30.9%) | -$12.88M(+25.2%) |
| Mar 2019 | - | -$3.21M(-8.6%) | -$10.29M(+9.0%) |
| Dec 2018 | -$9.45M(+142.8%) | -$3.52M(+81.3%) | -$9.45M(+17.3%) |
| Sep 2018 | - | -$1.94M(+19.9%) | -$8.05M(+11.7%) |
| Jun 2018 | - | -$1.62M(-31.7%) | -$7.21M(+20.2%) |
| Mar 2018 | - | -$2.37M(+11.4%) | -$6.00M(+54.3%) |
| Dec 2017 | -$3.89M(+196.7%) | -$2.13M(+93.7%) | -$3.89M(+120.6%) |
| Sep 2017 | - | -$1.10M(+169.1%) | -$1.76M(+165.1%) |
| Jun 2017 | - | -$408.00K(+58.8%) | -$665.00K(+158.8%) |
| Mar 2017 | - | -$257.00K | -$257.00K |
| Dec 2016 | -$1.31M | - | - |
FAQ
- What is Krystal Biotech, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. annual CFO year-on-year change?
- What is Krystal Biotech, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. quarterly CFO year-on-year change?
- What is Krystal Biotech, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. TTM CFO year-on-year change?
What is Krystal Biotech, Inc. annual cash flow from operations?
The current annual CFO of KRYS is $123.42M
What is the all time high annual CFO for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high annual cash flow from operations is $123.42M
What is Krystal Biotech, Inc. annual CFO year-on-year change?
Over the past year, KRYS annual cash flow from operations has changed by +$212.22M (+238.98%)
What is Krystal Biotech, Inc. quarterly cash flow from operations?
The current quarterly CFO of KRYS is $52.73M
What is the all time high quarterly CFO for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high quarterly cash flow from operations is $58.86M
What is Krystal Biotech, Inc. quarterly CFO year-on-year change?
Over the past year, KRYS quarterly cash flow from operations has changed by +$56.90M (+1365.09%)
What is Krystal Biotech, Inc. TTM cash flow from operations?
The current TTM CFO of KRYS is $195.40M
What is the all time high TTM CFO for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high TTM cash flow from operations is $195.40M
What is Krystal Biotech, Inc. TTM CFO year-on-year change?
Over the past year, KRYS TTM cash flow from operations has changed by +$212.14M (+1267.39%)